Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV.

Swanta N, Aryal S, Nejtek V, Shenoy S, Ghorpade A, Borgmann K.

J Neurovirol. 2020 Mar 19. doi: 10.1007/s13365-020-00834-3. [Epub ahead of print]

PMID:
32193795
2.

Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV.

Kim-Chang JJ, Donovan K, Loop MS, Hong S, Fischer B, Venturi G, Garvie PA, Kohn J, Rendina HJ, Woods SP, Goodenow MM, Nichols SL, Sleasman JW; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

AIDS. 2019 Dec 1;33(15):2363-2374. doi: 10.1097/QAD.0000000000002371. Erratum in: AIDS. 2020 Feb 1;34(2):333.

PMID:
31764101
3.

Markers of Microbial Translocation and Immune Activation Predict Cognitive Processing Speed in Heavy-Drinking Men Living with HIV.

Monnig MA, Kahler CW, Cioe PA, Monti PM, Mayer KH, Pantalone DW, Cohen RA, Ramratnam B.

Microorganisms. 2017 Sep 21;5(4). pii: E64. doi: 10.3390/microorganisms5040064.

4.

Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.

Abassi M, Morawski BM, Nakigozi G, Nakasujja N, Kong X, Meya DB, Robertson K, Gray R, Wawer MJ, Sacktor N, Boulware DR.

J Neurovirol. 2017 Jun;23(3):369-375. doi: 10.1007/s13365-016-0505-9. Epub 2016 Dec 19.

5.

Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women.

Wojna V, Robles L, Skolasky RL, Mayo R, Selnes O, de la Torre T, Maldonado E, Nath A, Meléndez LM, Lasalde-Dominicci J.

J Neurovirol. 2007 Dec;13(6):561-8.

6.

Associations Between Neurocognitive Impairment and Biomarkers of Poor Physiologic Reserve in a Clinic-Based Sample of Older Adults Living with HIV.

Yu KC, D'Avanzo PA, Nesheiwat L, Greene RE, Urbina A, Halkitis PN, Kapadia F.

J Assoc Nurses AIDS Care. 2017 Jan - Feb;28(1):55-66. doi: 10.1016/j.jana.2016.08.007. Epub 2016 Aug 27.

PMID:
27639980
7.

Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.

Lyons JL, Uno H, Ancuta P, Kamat A, Moore DJ, Singer EJ, Morgello S, Gabuzda D.

J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):371-9. doi: 10.1097/QAI.0b013e3182237e54.

8.

Plasma CXCL10 correlates with HAND in HIV-infected women.

Burlacu R, Umlauf A, Marcotte TD, Soontornniyomkij B, Diaconu CC, Bulacu-Talnariu A, Temereanca A, Ruta SM, Letendre S, Ene L, Achim CL.

J Neurovirol. 2020 Feb;26(1):23-31. doi: 10.1007/s13365-019-00785-4. Epub 2019 Aug 14.

PMID:
31414350
9.

Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.

Saloner R, Grelotti DJ, Tyree G, Sundermann EE, Ma Q, Letendre S, Heaton RK, Cherner M.

J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):475-482. doi: 10.1097/QAI.0000000000002183.

PMID:
31714426
10.

Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.

Goodkin K, Miller EN, Cox C, Reynolds S, Becker JT, Martin E, Selnes OA, Ostrow DG, Sacktor NC; Multicenter AIDS Cohort Study.

Lancet HIV. 2017 Sep;4(9):e411-e422. doi: 10.1016/S2352-3018(17)30098-X. Epub 2017 Jul 14.

11.

Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.

Mugendi AG, Kubo MN, Nyamu DG, Mwaniki LM, Wahome SK, Haberer JE.

Neurol Res Int. 2019 Oct 30;2019:5173289. doi: 10.1155/2019/5173289. eCollection 2019.

12.

The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.

Thames AD, Briones MS, Magpantay LI, Martinez-Maza O, Singer EJ, Hinkin CH, Morgello S, Gelman BB, Moore DJ, Heizerling K, Levine AJ.

AIDS. 2015 Jul 31;29(12):1483-91. doi: 10.1097/QAD.0000000000000706.

13.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.

Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre SL, Collier AC, Clifford DB, Gelman BB, Marra CM, McCutchan JA, Morgello S, Sacktor N, Jeste DV, Grant I, Heaton RK, Moore DJ; CHARTER and HNRP Groups.

J Int Neuropsychol Soc. 2019 May;25(5):507-519. doi: 10.1017/S1355617719000018. Epub 2019 Mar 20.

14.

Effects of smoking and alcohol use on neurocognitive functioning in heavy drinking, HIV-positive men who have sex with men.

Monnig MA, Kahler CW, Lee H, Pantalone DW, Mayer KH, Cohen RA, Monti PM.

AIDS Care. 2016;28(3):300-5. doi: 10.1080/09540121.2015.1093595. Epub 2015 Oct 7.

15.

Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.

Pérez-Santiago J, Schrier RD, de Oliveira MF, Gianella S, Var SR, Day TR, Ramirez-Gaona M, Suben JD, Murrell B, Massanella M, Cherner M, Smith DM, Ellis RJ, Letendre SL, Mehta SR.

J Neurovirol. 2016 Apr;22(2):191-200. doi: 10.1007/s13365-015-0384-5. Epub 2015 Oct 1.

16.

Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.

Cassol E, Misra V, Morgello S, Gabuzda D.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1087-97. doi: 10.1007/s11481-013-9512-2. Epub 2013 Nov 21. Review.

17.

Relationship between HIV stage and psychomotor speed neurocognitive score at a Kenyan sub-county hospital.

Kinuthia RN, Gakinya BN, Thigiti JM.

Afr J Prim Health Care Fam Med. 2016 Aug 31;8(1):e1-8. doi: 10.4102/phcfm.v8i1.1061.

18.

The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China.

Schrier RD, Gupta S, Riggs P, Cysique LA, Letendre S, Jin H, Spector SA, Singh KK, Wolfson T, Wu Z, Hong KX, Yu X, Shi C, Heaton RK; HNRC Group.

PLoS One. 2012;7(5):e32303. doi: 10.1371/journal.pone.0032303. Epub 2012 May 31.

19.

Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.

Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D.

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):234-43. doi: 10.1097/QAI.0b013e318256f3bc.

20.

Effects of trauma, economic hardship, and stress on neurocognition and everyday function in HIV.

Watson CW, Sundermann EE, Hussain MA, Umlauf A, Thames AD, Moore RC, Letendre SL, Jeste DV, Morgan EE, Moore DJ.

Health Psychol. 2019 Jan;38(1):33-42. doi: 10.1037/hea0000688. Epub 2018 Oct 29.

Supplemental Content

Support Center